ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
1 story in the last 7 days
The latest rq bio news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks rq bio across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
RQ Bio raised £85.5 million in Series A funding. The round supports the company's work on developing broad-spectrum antiviral therapies. RQ Bio focuses on creating treatments effective against multiple virus families.
Summaries by ByteBrief